Malaysia

Health product regulation in Malaysia is overseen by multiple authorities depending on product category. The Medical Device Authority (MDA), established under the Medical Device Act 2012 (Act 737), governs medical devices and in vitro diagnostics, while the National Pharmaceutical Regulatory Agency (NPRA), operating under the Control of Drugs and Cosmetics Regulations 1984 and the Sale of Drugs Act 1952, regulates pharmaceuticals, biologics, and related health products. Digital health solutions are subject to emerging frameworks guided by the Ministry of Health (MOH) and the Malaysian Communications and Multimedia Commission (MCMC). All health products intended for the Malaysian market must be registered with the relevant authority prior to sale or distribution, and the approval process generally involves a structured dossier review encompassing safety, quality, and efficacy or performance data.

For medical devices, registration follows a risk-based classification system (Class A through Class D), with higher-risk devices requiring more rigorous conformity assessment and, in some cases, mandatory local conformity assessment body (CAB) audits. Pharmaceutical submissions are accepted in the ASEAN Common Technical Dossier (ACTD) format, and ICH Common Technical Document (CTD) format is also recognized, reflecting Malaysia's alignment with ASEAN harmonization initiatives under the ASEAN Pharmaceutical Product Working Group (PPWG). A locally registered establishment, either a manufacturer or an authorized representative, is required for all product registrations. Notably, Malaysia has been progressively implementing the ASEAN Medical Device Directive (AMDD) framework and has introduced fast-track or expedited review pathways for products with prior approval from recognized reference agencies such as the US FDA, EMA, Health Canada, or TGA Australia, as well as for products addressing unmet medical needs or public health priorities.

Public sector procurement in Malaysia is centralized primarily through the Ministry of Health (MOH), which operates one of the largest government procurement systems in the country. The MOH Pharmacy Division manages the national formulary and coordinates procurement through a national tender process administered by the MOH Procurement Division and, for larger contracts, in coordination with the Ministry of Finance and the Government Procurement Division (Bahagian Perolehan Kerajaan). Products must appear on the Malaysian MOH Formulary or be approved for procurement to be eligible for public hospital and clinic supply. State-level health departments may conduct supplementary procurement for specific needs, but the bulk of pharmaceutical and device spending is driven by federal-level contracts. Price negotiation and health technology assessment (HTA), conducted by the Malaysian Health Technology Assessment Section (MaHTAS), play an increasingly significant role in formulary listing and reimbursement decisions for both pharmaceuticals and medical devices.

The private sector represents a substantial and growing share of the Malaysian health market, served through distributor networks, group purchasing organizations, and direct procurement by private hospital chains such as IHH Healthcare and KPJ Healthcare. Import duties and sales tax exemptions are available for certain categories of medical devices and pharmaceuticals, incentivizing market entry. Malaysia participates in regional and international procurement mechanisms selectively; donor-funded procurement through agencies such as UNICEF, the Global Fund, and USAID is limited given Malaysia's upper-middle-income status, though such channels may apply to niche public health programs. The government has articulated policies to support local manufacturing, including preferential procurement margins for locally manufactured products and incentives under the Malaysian Investment Development Authority (MIDA) for health industry investments, aligning with the national aspiration to develop Malaysia as a regional pharmaceutical and medical device manufacturing hub.